 New research is suggesting that a class of diabetes medications that are also used for weight loss, including Ozempic, may lower the risk of some obesity-related cancers. We get more from CBS correspondent Michael Toscano. The study published in the Journal of the American Medical Association compared patients with type 2 diabetes and treated with insulin against patients taking the class of drugs which includes medications like Ozempic.